Back
Novo Nordisk AS Vs. Manhattan Associates Industry Stock Comparison
Sell
44
NONOF
Novo Nordisk AS
Last Price:
$87.40
Seasonality Move:
4.97%
Sell
30
MANH
Manhattan Associates
Last Price:
$182.28
Seasonality Move:
6.7%
Sell
44
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.40. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Manhattan Associates (MANH)
is a Sell
Is Manhattan Associates a Buy, Sell or Hold?
-
The current Manhattan Associates [MANH] share price is $182.51. The Score for MANH is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
MANH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.40The current trend is relatively stagnant and NONOF is experiencing slight selling pressure.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $182.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MANH is experiencing slight selling pressure.
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.21 | Sell |
Relative Strength Index (14 RSI): | 55.26 | Buy |
Chaikin Money Flow: | -491 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.86 - 85.92) | Buy |
Bollinger Bands (100): | (86.07 - 113.91) | Sell |
MANH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -21.67 | Sell |
Relative Strength Index (14 RSI): | 28.46 | Sell |
Chaikin Money Flow: | -314815 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (179.37 - 266.05) | Sell |
Bollinger Bands (100): | (232.34 - 303.1) | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.26 | Buy |
20-day SMA: | 83.91 | Buy |
50-day SMA: | 88.56 | Sell |
200-day SMA: | 117.52 | Sell |
8-day EMA: | 83.46 | Buy |
20-day EMA: | 83.86 | Buy |
50-day EMA: | 89.08 | Sell |
200-day EMA: | 106.82 | Sell |
MANH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 184.69 | Sell |
20-day SMA: | 208.5 | Sell |
50-day SMA: | 252.02 | Sell |
200-day SMA: | 255.07 | Sell |
8-day EMA: | 187.55 | Sell |
20-day EMA: | 206.29 | Sell |
50-day EMA: | 236.92 | Sell |
200-day EMA: | 251.51 | Sell |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.05 per share, and an increase next year of $0.50 per share.
Novo Nordisk AS Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Manhattan Associates Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |